281 studies found for:    Open Studies | "Uterine Cervical Diseases"
Show Display Options
Rank Status Study
21 Recruiting Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions: Advanced Malignant Neoplasm;   Cervical Squamous Cell Carcinoma;   Endometrial Carcinoma;   Malignant Uterine Neoplasm;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Ovarian Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Renal Cell Carcinoma;   Solid Neoplasm;   Stage III Bladder Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Breast Cancer;   Stage IV Ovarian Cancer;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Bladder Cancer;   Stage IVA Cervical Cancer;   Stage IVB Bladder Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nanoparticle Albumin-Bound Rapamycin;   Other: Quality-of-Life Assessment
22 Recruiting Sentinel Lymph Node Biopsy Versus Systematic Pelvic Lymphadenectomy in Early-stage Cervival Cancer
Conditions: Cervical Cancer;   Surgery;   Quality of Life
Intervention: Procedure: no systematic pelvic lymphadnectomy
23 Not yet recruiting Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Pembrolizumab;   Radiation: Brachytherapy;   Drug: Cisplatin
24 Recruiting Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
Conditions: Cervical Intraepithelial Neoplasia;   Low-Grade Squamous Intraepithelial Lesions;   Papillomavirus Infections
Interventions: Drug: Aminolaevulinic acid;   Drug: Placebo
25 Not yet recruiting Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Estrogen Receptor Negative;   HER2/Neu Negative;   Neuroendocrine Neoplasm;   Progesterone Receptor Negative;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Cervical Cancer;   Stage IV Gastric Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Ovarian Cancer;   Stage IV Small Cell Lung Carcinoma;   Triple-Negative Breast Carcinoma
Interventions: Drug: Ferumoxytol;   Other: Laboratory Biomarker Analysis;   Drug: Liposomal Irinotecan;   Procedure: Magnetic Resonance Imaging;   Drug: Veliparib
26 Not yet recruiting Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer
Conditions: PFS;   OS;   Quality of Life
Interventions: Drug: NACT (Paclitaxel + Cisplatin or carboplatin);   Procedure: radical surgery
27 Recruiting the Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
Intervention: Drug: Tachosil
28 Recruiting Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005)
Condition: Cervical Cancer
Interventions: Drug: Taxane;   Procedure: radical trachelectomy
29 Recruiting DNA Methylation Biomarkers for Cervical Cancer Screening
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
Intervention:
30 Not yet recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Vulvar Cancer;   Stage IB2 Cervical Cancer;   Stage II Vulvar Cancer;   Stage IIA1 Cervical Cancer;   Stage IIA2 Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vulvar Cancer;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: High-Dose Rate Brachytherapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Triapine
31 Recruiting Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer
Condition: Cervical Carcinoma Stage IIB
Interventions: Radiation: Concurrent chemoirradiation;   Drug: Paclitaxel;   Procedure: Radical Surgery;   Drug: Cisplatin
32 Recruiting A Phase 1/2a Evaluation of the Safety and Efficacy of Adding AL3818 to Standard Platinum-Based Chemotherapy (AL3818-US-002)
Conditions: Endometrial Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma;   Cervical Carcinoma
Interventions: Drug: AL3818;   Drug: Carboplatin;   Drug: Paclitaxel
33 Recruiting Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Conditions: Cervical Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Vulvar Carcinoma;   Uterine Corpus Cancer;   Vulvar Carcinoma;   Peritoneal Neoplasms
Interventions: Other: Palliative Therapy;   Other: Palliative Therapy + idiographic
34 Recruiting Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Conditions: Human Papillomavirus;   High-Grade Squamous Intraepithelial Lesions
Interventions: Biological: TVGV-1;   Biological: GPI-0100;   Biological: Placebo
35 Recruiting HPV Integration Testing for Human Papillomavirus-Positive Women
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
Intervention: Procedure: TCT,HPV,colposcopic inspection
36 Recruiting HPV Integration Testing for Cervical Cancer Screening
Conditions: Cervical Cancer;   Cervical Intraepithelial Neoplasia
Intervention: Procedure: TCT,HPV,colposcopic inspection
37 Not yet recruiting Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer
Conditions: Precancerous Condition;   Cervical Cancer
Intervention: Device: In Vivo Confocal Microscopy Probe
38 Recruiting Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer
Conditions: Cervical Squamous Cell Carcinoma;   Cervical Adenocarcinoma;   Malignant Neoplasm of Cervix Stage IB1;   Stage IIA1 Cervical Cancer
Intervention: Procedure: Nerve-Sparing Radical Hysterectomy
39 Recruiting A Phase 1/2a Evaluation of the Safety, Pharmacokinetics and Efficacy of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)
Conditions: Endometrial Cancer;   Ovarian Cancer;   Cervical Cancer
Intervention: Drug: AL3818
40 Recruiting Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards the Development of Personalized Biomarkers in Clinical Oncology (PAIR HPV : Human PapillomaVirus)
Condition: Cervical Cancer
Interventions: Procedure: Tumor biopsy;   Procedure: Blood sampling

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years